Unleash Immuno Oncolytics, Inc.

12:00 PM - 12:15 PM, Tuesday, June 4,2019 ・ SuS - Hall E, Booth 3971, Level 200
Immuno-oncology company developing oncolytic viruses that target the stromal layer of metastatic cancers, which is connective tissue found in all organs and is often a host site for cancers that are resistant to current therapies. These viruses conditionally replicate and selectively target malignant and tumor-associated stroma cells to facilitate an infection that eradicates the cancer and prevents recurrence. Additionally, these viruses induce signals that trigger the natural immune response to eliminate malignant cells.
Speaker
photo
CEO
Unleash Immuno Oncolytics, Inc.